ACTRN12613001037796已完成3 期
Effect of exercise intensity on cardiac and vascular function, and intra-abdominal fat in obese children and adolescents.
Professor Jeff Coombes0 个研究点目标入组 30 人开始时间: 2013年9月18日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 7 Years 至 16 Years(—)
- 性别
- All
入选标准
- •Gender: Males and females are eligible. The study will endeavour to recruit approximately equal numbers of males and females.
- •Body mass index: Obese individuals, with a body mass index greater than or equal to an equivalent of 30kg/m2 in adults are eligible. Eligibility of obese individuals with a BMI greater than 99th percentile (CDC Growth Charts) will be assessed on an individual basis.
- •Age: Individuals aged 7-16 years old (inclusive) are eligible.
- •Ethnicity: All ethnic groups are eligible for the study. There is likely to be incidental recruitment of participants of Aboriginal or Torres Strait Islander ethnicity.
- •Blood pressure: Individuals with blood pressure less than the 95th percentile for systolic or diastolic values measured upon three or more occasions will be eligible
- •Lipid control: Individuals with fasting total cholesterol less than 5.5mmol/L and low-density lipoprotein cholesterol less than 3.0mmol/L are eligible.
- •Willingness to participate: Participants must be willing to be randomised to either High Intensity Aerobic Interval Training, Moderate Intensity Exercise or Control groups and to follow the protocol that they have been assigned.
- •Successful completion of self-monitoring: Successful seven accelerometer compliance and diet diary completion will be an indication of willingness to participate and will be required for eligibility
排除标准
- •- Unwilling to participate or participation in another study
- •- Coronary heart disease
- •- Congenital cardiac abnormalities (i.e. anomalous coronary artery origins)
- •- Family history of hypertrophic obstructive cardiomyopathy
- •- Any abnormality during the resting or exercise stress echo that indicates it would be unsafe to participate in the intervention
- •- Self reported kidney failure
- •- Any major organ transplant
- •- Considerable pulmonary disease including severe or poorly controlled asthma or exercise induced asthma
- •- Diabetes
- •- Epilepsy or history of seizures
- •- Orthopaedic and/or neurological limitations to exercise
- •- Diagnosed Attention Deficit Hypersensitivity Disorder (ADHD)
- •- Medications such as steroids
- •- Conditions not specifically mentioned above may serve as criteria for exclusion at discretion of the clinical site
研究者
相似试验
已完成
2 期
Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I)Cardiovascular DiseasesHeart DiseasesMetabolic Syndrome XObesityInsulin ResistanceHyperlipidemiaNCT00200993National Heart, Lung, and Blood Institute (NHLBI)
尚未招募
Unknown
High Intensity Exercise & its Effect in middle age vs old age adults with Low Back PaiCTRI/2023/05/053255niversity Grants Commission
已完成
不适用
Effects of exercise training on cardiovascular and autonomic function among renal transplant recipientsZ94.0N18.5G99.0Kidney transplant statusChronic kidney disease, stage 5Autonomic neuropathy in endocrine and metabolic diseasesDRKS00004287Aristotle University of Thessaloniki35
招募中
不适用
Effect of physical exercise on the condition of how much the heart and lung function, about tiredness and quality of life in cancer patients who underwent bone marrow transplantation in up to 100 dayscardiovascular diseasesbone marrow transplantationsolid and hematological neoplasmscardiopulmonary functionmuscle strengthfatiguephysical functionquality of lifephysical exercisecardiorespiratory capacityoncohematologicalneoplamsexerciseCancer Care FacilitiesCardiorespiratory FitnesscancerHemic and lymphatic diseasesG11.427.410.698.277N02.278.421.556.070E02.095.147.725.040G11.427.685.500RBR-887gqvsniversidade do Estado de Santa Catarina
已完成
不适用
Exercise and HypertensioCirculatory SystemCardiologyHypertensionPACTR201112000341237amina Sikiru484
